Gestational diabetes – Vitamin D and Calcium provided huge benefits – RCT
Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial.
Public Health Nutr. 2015 Mar 20:1-8. [Epub ahead of print]
Karamali M 1, Asemi Z 2, Ahmadi-Dastjerdi M 1, Esmaillzadeh A 3.
1 Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, Islamic Republic of Iran.
2 Department of Nutrition, Research Center for Biochemistry and Nutrition in Metabolic Diseases,Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.
3 Food Security Research Center,Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran.
Racial/Ethnic Differences in the Percentage of Gestational Diabetes Mellitus Cases Attributable to Overweight and Obesity, Florida, 2004-2007
Gestational Diabetes Risk Factors Mayo ClinicAge greater than 25, Family or personal health history,BMI> 30, Nonwhite raceWebMD adds the following factorsPreviously giving birth to a baby over 9 pounds, given birth to a stillborn baby, previously had gestational diabetes OBJECTIVE:
The present study was designed to assess the effects of Ca+vitamin D supplementation on pregnancy outcomes in women with gestational diabetes mellitus (GDM).
DESIGN:
A randomized, double-blind, placebo-controlled trial was conducted among sixty women with GDM. Participants were divided into two groups to receive Ca+vitamin D supplements or placebo. Individuals in the Ca+vitamin D group (n 30) received 1000 mg Ca/d and two pearls containing 1250 µg (50 000 IU) of cholecalciferol (vitamin D3) during the intervention (one at study baseline and another at day 21 of the intervention); those in the placebo group (n 30) received two placebos of vitamin D at the mentioned times and placebos of Ca every day for 6 weeks. Pregnancy outcomes were determined.
SETTING:
A urban community setting in Arak, Iran.
SUBJECTS:
Sixty women with GDM and their newborns, living in Arak, Iran were enrolled.
RESULTS:
Women treated with Ca+vitamin D had a significant decrease in caesarean section rate (23·3 % v. 63·3 %, P=0·002) and maternal hospitalization (0 v. 13·3 %, P=0·03) compared with those receiving placebo. In addition, newborns of GDM women randomized to Ca+vitamin D had no case of macrosomia, while the prevalence of macrosomia among those randomized to placebo was 13·3 % (P=0·03). Lower rates of hyperbilirubinaemia (20·0 % v. 56·7 %, P=0·03) and hospitalization (20·0 % v. 56·7 %, P=0·03) were also seen in the supplemented group of newborns than in the placebo group.
CONCLUSIONS:
Ca+vitamin D supplementation for 6 weeks among pregnant women with GDM led to decreased caesarean section rate and maternal hospitalization, and decreased macrosomia, hyperbilirubinaemia and hospitalization in newborns.
PMID: 25790761
Publisher charges $45 for the PDF
Vitamin D Life pages listed in BOTH the categories Diabetes and Pregnancy
{category}